United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
303.92
+4.24 (1.41%)
At close: May 15, 2025, 4:00 PM
304.89
+0.97 (0.32%)
After-hours: May 15, 2025, 5:57 PM EDT
United Therapeutics Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$392.00
Upside
+28.98%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $425 | Strong Buy | Reiterates | $425 | +39.84% | May 5, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $355 → $350 | Buy | Maintains | $355 → $350 | +15.16% | May 1, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $346 → $348 | Hold | Maintains | $346 → $348 | +14.50% | May 1, 2025 |
| Wells Fargo | Wells Fargo | Buy → Hold Downgrades $395 → $314 | Buy → Hold | Downgrades | $395 → $314 | +3.32% | Apr 25, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $357 → $355 | Buy | Maintains | $357 → $355 | +16.81% | Apr 21, 2025 |
| B of A Securities | B of A Securities | Sell → Hold Upgrades $314 | Sell → Hold | Upgrades | $314 | +3.32% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $425 | Strong Buy | Reiterates | $425 | +39.84% | Feb 27, 2025 |
| UBS | UBS | Strong Buy Maintains $415 → $475 | Strong Buy | Maintains | $415 → $475 | +56.29% | Jan 8, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $243 → $302 | Hold | Maintains | $243 → $302 | -0.63% | Nov 1, 2024 |
| Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Maintains $319 → $344 | Strong Buy | Maintains | $319 → $344 | +13.19% | Oct 31, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $575 → $600 | Buy | Maintains | $575 → $600 | +97.42% | Oct 31, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $360 → $400 | Strong Buy | Maintains | $360 → $400 | +31.61% | Oct 31, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $400 → $425 | Strong Buy | Maintains | $400 → $425 | +39.84% | Oct 31, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $350 → $400 | Strong Buy | Maintains | $350 → $400 | +31.61% | Oct 21, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $315 → $432 | Strong Buy | Maintains | $315 → $432 | +42.14% | Sep 23, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $400 → $575 | Buy | Maintains | $400 → $575 | +89.19% | Aug 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.